eEF2 and phosphorylated eEF2 are prognostic indicators of HCC patient survival [68], and that eEF2 kinase promotes HCC angiogenesis and tumor progression through SP1/KLF5-mediated VEGF expression [69]. Here, SP1 is linked to hepatocellular carcinoma.